We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Structure of Rabies Virus Nucleocapsid Revealed

By Biotechdaily staff writers
Posted on 07 Jul 2006
Researchers have found how RNA viruses such as rabies, measles, and Ebola protect the genetic information contained in their single strand of RNA from destruction by the human innate immune system.

Investigators at the Institut de Virologie Moléculaire et Structurale (IVMS, Grenoble, France) and the European Molecular Biology Laboratory (Grenoble, France) bombarded crystals of rabies virus RNA bound to nucleoprotein--a structure called a nucleocapsid--with high-intensity x-rays. More...
A scattering pattern with resolution of 3.5 angstroms was obtained showing an undecameric (11-member) ring.

The structural evidence allowed the investigators to propose in the June 15, 2006, online edition of Science that polymerization of the nucleoprotein was achieved by domain exchange between protomers, with flexible hinges allowing nucleocapsid formation. The two core domains of the nucleoprotein were clamped around the RNA at their interface and shielded it from the environment.

"Nucleoprotein is vital for the rabies virus,” explained senior author Dr. Rob Ruigrok, director of the IVMS. "It is one of the few proteins that the virus brings into the host cell and it wraps around the RNA like a protection shield. Without this shield the RNA would be degraded by the enzymes of the human immune system that try to eliminate the invader. This dynamic mechanism makes nucleoproteins an excellent drug target. Small agents that bind to the protein in such a way to block its flexibility and keep it in the closed state would prevent replication of the virus and would stop it from spreading.”



Related Links:
Institut de Virologie Moléculaire et Structurale
European Molecular Biology Laboratory

New
Gold Member
Automatic Hematology Analyzer
CF9600
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
POC Immunoassay Analyzer
Procise DX
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.